Cathcart P - Search Results

1

Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology.

Droz JP, Aapro M, Balducci L, Boyle H, Van den Broeck T, Cathcart P, Dickinson L, Efstathiou E, Emberton M, Fitzpatrick JM, Heidenreich A, Hughes S, Joniau S, Kattan M, Mottet N, Oudard S, Payne H, Saad F, Sugihara T. Droz JP, et al. Among authors: cathcart p. Lancet Oncol. 2014 Aug;15(9):e404-14. doi: 10.1016/S1470-2045(14)70018-X. Lancet Oncol. 2014. PMID: 25079103 Review.

2

A description of radical nephrectomy practice and outcomes in England: 1995-2002.

Nuttall M, Cathcart P, van der Meulen J, Gillatt D, McIntosh G, Emberton M. Nuttall M, et al. Among authors: cathcart p. BJU Int. 2005 Jul;96(1):58-61. doi: 10.1111/j.1464-410X.2005.05567.x. BJU Int. 2005. PMID: 15963121

3

When thinking of initiating medical therapy for lower urinary tract symptoms, ask about cataracts.

Cathcart P, Rajendram R, Rajendram R, Emberton M. Cathcart P, et al. BJU Int. 2005 Dec;96(9):1217-8. doi: 10.1111/j.1464-410X.2005.06027.x. BJU Int. 2005. PMID: 16287433 No abstract available.

4

Incidence of primary and recurrent acute urinary retention between 1998 and 2003 in England.

Cathcart P, van der Meulen J, Armitage J, Emberton M. Cathcart P, et al. J Urol. 2006 Jul;176(1):200-4; discussion 204. doi: 10.1016/S0022-5347(06)00509-X. J Urol. 2006. PMID: 16753401

5

The thermo-expandable metallic stent for managing benign prostatic hyperplasia: a systematic review.

Armitage JN, Rashidian A, Cathcart PJ, Emberton M, van der Meulen JH. Armitage JN, et al. Among authors: cathcart pj. BJU Int. 2006 Oct;98(4):806-10. doi: 10.1111/j.1464-410X.2006.06399.x. Epub 2006 Jul 28. BJU Int. 2006. PMID: 16879446 Review.

6

The effect of neoadjuvant androgen suppression on prostate cancer-related outcomes after high-intensity focused ultrasound therapy.

Uchida T, Illing RO, Cathcart PJ, Emberton M. Uchida T, et al. BJU Int. 2006 Oct;98(4):770-2. doi: 10.1111/j.1464-410X.2006.06369.x. Epub 2006 Jul 28. BJU Int. 2006. PMID: 16879448

7

To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?

Uchida T, Illing RO, Cathcart PJ, Emberton M. Uchida T, et al. BJU Int. 2006 Sep;98(3):537-9. doi: 10.1111/j.1464-410X.2006.06297.x. BJU Int. 2006. PMID: 16925749

8

Mortality in men admitted to hospital with acute urinary retention: database analysis.

Armitage JN, Sibanda N, Cathcart PJ, Emberton M, van der Meulen JH. Armitage JN, et al. Among authors: cathcart pj. BMJ. 2007 Dec 8;335(7631):1199-202. doi: 10.1136/bmj.39377.617269.55. Epub 2007 Nov 8. BMJ. 2007. PMID: 17991937 Free PMC article.

9

Life after prostate cancer. Time to evaluate focal therapy.

Cathcart P, Ahmed HU, Moore C, Emberton M. Cathcart P, et al. BMJ. 2010 Feb 23;340:c1057. doi: 10.1136/bmj.c1057. BMJ. 2010. PMID: 20179109 No abstract available.

10

Volume-mortality for cystectomy. Centralisation of cancer services vindicated.

Cathcart PJ, van der Meulen J, Emberton M, Kelly J. Cathcart PJ, et al. BMJ. 2010 Jun 22;340:c3336. doi: 10.1136/bmj.c3336. BMJ. 2010. PMID: 20570878 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters